Decatur, AL, United States
Letco Medical LLC recalls
2 recalls recorded since 2018, most recently on 12 September 2025. 1 is listed as ongoing. Status and classification are as published by the FDA.
Recalls2
Ongoing (FDA)1
Terminated or completed1
Class I (FDA)0
Ongoing Class III Drugs
- Recall started
- 12 September 2025
- Reason
- Labeling: Not Elsewhere Classified
- Distribution
- Product was distributed to: Letco Medical, LLC 1316 Commerce Drive Decatur, AL 35601 Product was further distributed to 44 compounding pharmacies and 2 distributors.
- Initiated
- Voluntary: Firm initiated
- Recall number
- D-0138-2026
- Espumil, Lipophilic foam base, 500 ml, 24G15-T02-115604
Terminated Class II Drugs
- Recall started
- 10 January 2020
- Terminated
- 7 April 2021
- Reason
- Subpotent
- Distribution
- United States, Australia, Canada, Israel, Philippines, Taiwan.
- Initiated
- Voluntary: Firm initiated
- Recall number
- D-0780-2020
- Estriol USP Micronized a) 100 gm NDC 62991-2159-04; b) 1 gm NDC 62991-2159-01; c) 1 kg NDC 62991-2159-06; d) 25 gm NDC 62991-2159-03; e) 500 gm NDC 62991-2159-05; f) 5 gm NDC 62991-2159-02, Rx Only Repackaged by: Letco M
A terminated FDA recall means the FDA has determined that all reasonable efforts to remove or correct the product have been made. What statuses mean.